Point of care and factor concentrate-based coagulation algorithms

Transfusion Medicine and Hemotherapy

Volumn 42, Issue 2, 2015, Pages 115-121

  Theusinger, Oliver M ^a   Stein, Philipp ^a   Levy, Jerrold H ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bleeding; Cardiac surgery; Goal directed transfusions; Patient blood management; POC; Point of care devices; ROTEM ; Thrombelastometry; Transfusion management; Trauma

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 CONCENTRATE; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX;

ALGORITHM; BLOOD CLOTTING; BLOOD TRANSFUSION; COAGULOMETER; COST CONTROL; ERYTHROCYTE; EVIDENCE BASED PRACTICE; HEALTH CARE QUALITY; HEMATOLOGICAL PROCEDURE; HUMAN; POINT OF CARE TESTING; REVIEW; ROTATIONAL THROMBOELASTOMETRY; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER; THROMBOELASTOGRAPH; THROMBOELASTOGRAPHY; VISCOELASTICITY;

EID: 84928482180     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000381320     Document Type: Review

References (73)

1. Carson JL, Carless PA, Hebert PC: Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4:CD002042.
2. Goodnough LT, Shander A: Patient blood management. Anesthesiology 2012; 116: 1367-1376.
3. Shander A, Hofmann A, Isbister J, Van Aken H: Patient blood management-the new frontier. Best Pract Res Clin Anaesthesiol 2013; 27: 5-10.
4. Spahn DR, Goodnough LT: Alternatives to blood transfusion. Lancet 2013; 381: 1855-1865.
5. Williamson LM, Devine DV: Challenges in the management of the blood supply. Lancet 2013; 381: 1866-1875.
6. Park MS, Martini WZ, Dubick MA, Salinas J, Butenas S, Kheirabadi BS, Pusateri AE, Vos JA, Guymon CH, Wolf SE, Mann KG, Holcomb JB: Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 2009; 67: 266-276.
7. Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent JL, Rossaint R: Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17:R76.
8. Davenport R, Manson J, De'Ath H, Platton S, Coates A, Allard S, Hart D, Pearse R, Pasi KJ, MacCallum P, Stanworth S, Brohi K: Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39: 2652-2658.
9. Johansson PI, Stissing T, Bochsen L, Ostrowski SR: Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Mede 2009; 17: 45.
10. Beynon C, Jakobs M, Rizos T, Unterberg AW, Sakowitz OW: Rapid bedside coagulometry prior to urgent neurosurgical procedures in anticoagulated patients. Br J Neurosurg 2014; 28: 29-33.
11. Cotte J, D'Aanda E, Chauvin V, Kaiser E, Meaudre E: Point-of-care coagulation testing for trauma patients in a military setting: a prospective study. J Spec Oper Med 2013; 13: 59-62.
12. Nusa D, Harvey I, Almansouri AY, Wright S, Neeman T, Ahmad O, Hughes AR, Lueck CJ: Assessment of point-of-care measurement of international normalised ratio using the CoaguChek XS plus system in the setting of acute ischaemic stroke. Intern Med J 2013; 43: 1205-1209.
13. Chavez JJ, Weatherall JS, Strevels SM, Liu F, Snider CC, Carroll RC: Evaluation of a point-of-care coagulation analyzer on patients undergoing cardiopulmonary bypass surgery. J Clin Anesth 2004; 16: 7-10.
14. Hartert H: Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschr 1948; 26: 577-583.
15. Luddington RJ: Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27: 81-90.
16. Theusinger OM, Nurnberg J, Asmis LM, Seifert B, Spahn DR: Rotation thromboelastometry (ROTEM) stability and reproducibility over time. Eur J Cardiothorac Surg 2010; 37: 677-683.
17. Hiippala ST: Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis 1995; 6: 743-746.
18. Theusinger OM, Baulig W, Asmis LM, Seifert B, Spahn DR: In vitro factor XIII supplementation increases clot firmness in rotation thromboelastometry (ROTEM). Thromb Haemost 2010; 104: 385-391.
19. Theusinger OM, Madjdpour C, Spahn DR: Resuscitation and transfusion management in trauma patients: emerging concepts. Curr Opin Crit Care 2012; 18: 661-670.
20. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Stahel PF, Vincent JL, Spahn DR; Task Force for Advanced Bleeding Care in Trauma: Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14:R52.
21. Schochl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, Arndt C, Hanke A, Voelckel W, Solomon C: Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15:R83.
22. Theusinger OM, Felix C, Spahn DR: Strategies to reduce the use of blood products: a European perspective. Curr Opin Anaesthesiol 2012; 25: 59-65.
23. Theusinger OM, Wanner GA, Emmert MY, Billeter A, Eismon J, Seifert B, Simmen HP, Spahn DR, Baulig W: Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011; 113: 1003-1012.
24. Chapman MP, Moore EE, Ramos CR, Ghasabyan A, Harr JN, Chin TL, Stringham JR, Sauaia A, Silliman CC, Banerjee A: Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg 2013; 75: 961-967.
25. Schlimp CJ, Voelckel W, Inaba K, Maegele M, Schochl H: Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/-fresh frozen plasma) on plasma fibrinogen level and fibrinbased clot strength (FIBTEM) in major trauma: a retrospective study. Scand J Trauma Resusc Emerg Med 2013; 21: 74.
26. Schochl H, Schlimp CJ, Voelckel W: Perioperative coagulation management in multiple trauma patients based on viscoelastic test results (in German). Unfallchirurg 2014; 117: 111-117.
27. Schochl H, Forster L, Woidke R, Solomon C, Voelckel W: Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia 2010; 65: 199-203.
28. Schochl H, Cotton B, Inaba K, Nienaber U, Fischer H, Voelckel W, Solomon C: FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011; 15:R265.
29. Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T: Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br J Anaesth 2015; 114: 91-102.
30. Casutt M, Konrad C, Schuepfer G: Effect of rivaroxaban on blood coagulation using the viscoelastic coagulation test ROTEMTM. Anaesthesist 2012; 61: 948-953.
31. Franchini M: The platelet function analyzer (PFA-100): an update on its clinical use. Clin Lab 2005; 51: 367-372.
32. Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J: First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011; 115: 1179-1191.
33. Hazarbasanov D, Velchev V, Finkov B, Postadjian A, Kostov E, Rifai N, Aradi D: Tailoring clopidogrel dose according to multiple electrode aggregometry decreases the rate of ischemic complications after percutaneous coronary intervention. J Thromb Thrombolysis 2012; 34: 85-90.
34. Chowdhury M, Shore-Lesserson L, Mais AM, Leyvi G: Thromboelastograph with platelet mappingTM predicts postoperative chest tube drainage in patients undergoing coronary artery bypass grafting. J Cardiothorac Vasc Anesth 2014; 28: 217-223.
35. Carroll RC, Chavez JJ, Snider CC, Meyer DS, Muenchen RA: Correlation of perioperative platelet function and coagulation tests with bleeding after cardiopulmonary bypass surgery. J Lab Clin Med 2006; 147: 197-204.
36. Yu PJ, Cassiere HA, Dellis SL, Manetta F, Stein J, Hartman AR: P2y12 platelet function assay for assessment of bleeding risk in coronary artery bypass grafting. J Cardiac Surg 2014; 29: 312-316.
37. Dietrich GV, Schueck R, Menges T, Kiesenbauer NP, Fruehauf AC, Marquardt I: Comparison of four methods for the determination of platelet function in whole blood in cardiac surgery. Thromb Res 1998; 89: 295-301.
38. Slaughter TF, Sreeram G, Sharma AD, El-Moalem H, East CJ, Greenberg CS: Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagul Fibrinolysis 2001; 12: 85-93.
39. Alstrom U, Granath F, Oldgren J, Stahle E, Tyden H, Siegbahn A: Platelet inhibition assessed with Verifynow, flow cytometry and Platelet Mapping in patients undergoing heart surgery. Thromb Res 2009; 124: 572-577.
40. Orlov D, McCluskey SA, Selby R, Yip P, Pendergrast J, Karkouti K: Platelet dysfunction as measured by a point-of-care monitor is an independent predictor of high blood loss in cardiac surgery. Anesth Analg 2014; 118: 257-263.
41. Palmer JD, Sparrow OC, Iannotti F: Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 1994; 35: 1061-1065.
42. Naidech AM, Bernstein RA, Levasseur K, Bassin SL, Bendok BR, Batjer HH, Bleck TP, Alberts MJ: Platelet activity and outcome after intracerebral hemorrhage. Ann Neurol 2009; 65: 352-356.
43. Bachelani AM, Bautz JT, Sperry JL, Corcos A, Zenati M, Billiar TR, Peitzman AB, Marshall GT: Assessment of platelet transfusion for reversal of aspirin after traumatic brain injury. Surgery 2011; 150: 836-843.
44. Campbell PG, Sen A, Yadla S, Jabbour P, Jallo J: Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review. World Neurosurg 2010; 74: 279-285.
45. Nishijima DK, Zehtabchi S, Berrong J, Legome E: Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use: a systematic review. J Trauma Acute Care Surg 2012; 72: 1658-1663.
46. Davis PK, Musunuru H, Walsh M, Cassady R, Yount R, Losiniecki A, Moore EE, Wohlauer MV, Howard J, Ploplis VA, Castellino FJ, Thomas SG: Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy. Neurocrit Care 2013; 18: 201-208.
47. Bansal V, Fortlage D, Lee J, Doucet J, Potenza B, Coimbra R: A new clopidogrel (Plavix) point-of-care assay: rapid determination of antiplatelet activity in trauma patients. J Trauma 2011; 70: 65-70.
48. Solomon C, Traintinger S, Ziegler B, Hanke A, Rahe-Meyer N, Voelckel W, Schochl H: Platelet function following trauma. A multiple electrode aggregometry study. Thromb Haemost 2011; 106: 322-330.
49. Mahambrey T, Pendry K, Nee A, Bonney S, Nee PA: Critical care in emergency department: massive haemorrhage in trauma. Emerg Med J 2013; 30: 9-14.
50. Spahn DR, Rossaint R: Coagulopathy and blood component transfusion in trauma. Br J Anaesth 2005; 95: 130-139.
51. Theusinger OM, Baulig W, Seifert B, Emmert MY, Spahn DR, Asmis LM: Relative concentrations of haemostatic factors and cytokines in solvent/detergenttreated and fresh-frozen plasma. Br J Anaesth 2011; 106: 505-511.
52. Theusinger OM, Spahn DR, Ganter MT: Transfusion in trauma: why and how should we change our current practice? Curr Opin Anaesthesiol 2009; 22: 305-312.
53. Godje O, Gallmeier U, Schelian M, Grunewald M, Mair H: Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 2006; 54: 26-33.
54. Theusinger OM: The inhibiting effect of factor XIII on hyperfibrinolysis. Anesth Analg 2012; 114: 1149-1150.
55. Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C: Goaldirected coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14:R55.
56. Sorensen B, Spahn DR, Innerhofer P, Spannagl M, Rossaint R: Clinical review: prothrombin complex concentrates-evaluation of safety and thrombogenicity. Crit Care 2011; 15: 201.
57. Preston FE, Laidlaw ST, Sampson B, Kitchen S: Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): Efficacy and safety in 42 patients. Br J Haematol 2002; 116: 619-624.
58. Nienaber U, Innerhofer P, Westermann I, Schochl H, Attal R, Breitkopf R, Maegele M: The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury 2011; 42: 697-701.
59. Pape HC, Neugebauer E, Ridley Saxon A, Chiara O, Nielsen TG., Christensen CM: Cost-drivers in acute treatment of severe trauma in Europe: a systematic review of literature. Eur J Trauma Emerg Surg 2009; 35: 61-66.
60. Theusinger OM, Stein P, Spahn DR: Transfusion strategy in multiple trauma patients. Curr Opin Crit Care 2014; 20: 646-655.
61. Theusinger OM, Stein P, Spahn DR: Applying 'patient blood management' in the trauma center. Curr Opin Anaesthesiol 2014; 27: 225-232.
62. Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS: Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes. Blood 1982; 59: 1272-1278.
63. Castaman G, Goodeve A, Eikenboom J, European Group on von Willebrand Disease: Principles of care for the diagnosis and treatment of von Willebrand disease. Haematologica 2013; 98: 667-674.
64. Beynon C, Sakowitz OW, Unterberg AW: Multiple electrode aggregometry in antiplatelet-related intracerebral haemorrhage. J Clin Neurosci 2013; 20: 1805-1806.
65. Theusinger OM, Levy JH: Point of care devices for assessing bleeding and coagulation in the trauma patient. Anesthesiol Clin 2013; 31: 55-65.
66. O'Keeffe T, Refaai M, Tchorz K, Forestner JE, Sarode R: A massive transfusion protocol to decrease blood component use and costs. Arch Surg 2008; 143: 686-690; discussion 690-691.
67. Despotis GJ, Grishaber JE, Goodnough LT: The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Transfusion 1994; 34: 290-296.
68. Spiess BD, Gillies BS, Chandler W, Verrier E: Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 1995; 9: 168-173.
69. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA: Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88: 312-319.
70. Nuttall GA, Oliver WC, Santrach PJ, Bryant S, Dearani JA, Schaff HV, Ereth MH: Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001; 94: 773-781; discussion 5A-6A.
71. Capraro L, Kuitunen A, Salmenpera M, Kekomaki R: On-site coagulation monitoring does not affect hemostatic outcome after cardiac surgery. Acta Anaesthesiol Scand 2001; 45: 200-206.
72. Royston D, von Kier S: Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86: 575-578.
73. Avidan MS, Alcock EL, Da Fonseca J, Ponte J, Desai JB, Despotis GJ, Hunt BJ: Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004; 92: 178-186.